Cite
HARVARD Citation
Sashegyi, A. et al. (2017). Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials. Journal of chemotherapy. pp. 62-64. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sashegyi, A. et al. (2017). Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials. Journal of chemotherapy. pp. 62-64. [Online].